{
    "nct_id": "NCT06386887",
    "official_title": "The Feasibility, Safety, and Clinical Outcomes of Fasting During Neoadjuvant Chemotherapy in Patients With Epithelial Ovarian Cancer",
    "inclusion_criteria": "* Age 18 years and above\n* Participants with confirmed diagnosis of primary epithelial ovarian cancer (EOC) by internal cytologic or histologic evaluation (including fallopian tube and primary peritoneal cancer)\n* Participant who had undergone laparoscopic evaluation or laparotomy for diagnosis but did not proceed with surgical debulking\n* Participants with stage III or IV EOC planned to undergo chemotherapy including neoadjuvant chemotherapy\n* Participants with recurrent epithelial ovarian cancer who will receive platinum-based chemotherapy\n* Any invasive ovarian cancer histology\n* Normal cognitive function\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Age <18 years\n* Malignant complete or partial bowel obstruction confirmed on imaging.\n* Participants unable to provide informed consent.\n* BMI <18\n* Participants diagnosed with severe malnutrition as assessed by study dietitian\n* Type I diabetes on insulin\n* Absence of pretreatment CT abdomen and pelvis imaging or >4-6 weeks between imaging and cycle 1 of chemotherapy.",
    "miscellaneous_criteria": ""
}